ArticleCancers2021

DPP4 Inhibitor Sitagliptin Enhances Lymphocyte Recruitment and Prolongs Survival in a Syngeneic Ovarian Cancer Mouse Model.

Amy L Wilson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.